I
Initiator Pharma A/S
STO:INIT
Initiator Pharma A/S
STO:INIT
Price:
2.84
SEK
-0.35%
Market Cap:
kr194.4m
Initiator Pharma A/S
Intangible Assets
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Initiator Pharma A/S
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Initiator Pharma A/S
STO:INIT
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Intangible Assets
kr9.1B
|
CAGR 3-Years
657%
|
CAGR 5-Years
177%
|
CAGR 10-Years
78%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Intangible Assets
kr45m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Galecto Inc
NASDAQ:GLTO
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Intangible Assets
€3.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Intangible Assets
kr6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
51%
|
|
No Stocks Found
Initiator Pharma A/S
Glance View
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
INIT
Intrinsic Value
8.14
SEK
Undervaluation 65%
I
See Also
What is Initiator Pharma A/S's Intangible Assets?
Intangible Assets
0
DKK
0
DKK
Based on the financial report for Dec 31, 2024, Initiator Pharma A/S's Intangible Assets amounts to 0 DKK.
